US 10125134
KRas G12C inhibitors
granted A61PA61P35/00A61P35/02
Quick answer
US patent 10125134 (KRas G12C inhibitors) held by Mirati Therapeutics, Inc. expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00